Skip to main content
. 2018 Aug 31;6(3):59. doi: 10.3390/vaccines6030059

Table 3.

Multivariable regression results showing risk factors for inpatient mortality among the total cohort controlling for primary diagnosis.

Factors Risk Ratio 95% CI p-Value
Age in Years at Admission
75–84 vs. 65–74 1.35 1.23 1.49 <0.0001
85–89 vs. 65–74 2.07 1.86 2.30 <0.0001
90+ vs. 65–74 2.49 2.24 2.78 <0.0001
Sex: Male vs. Female 0.95 0.89 1.02 0.17
Patient Location: NCHS Urban–Rural Code
Central counties of metro areas of ≥1 million population (Ref) - - - -
Fringe counties of metro areas of ≥1 million population 0.98 0.88 1.09 0.69
Counties in metro areas of 250,000–999,999 population 1.13 1.02 1.25 0.02
Counties in metro areas of 50,000–249,999 population 1.39 1.23 1.58 <0.0001
Micropolitan counties 1.05 0.88 1.24 0.62
Not metropolitan or micropolitan counties 1.44 1.22 1.68 <0.0001
Median Household Income National Quartile for Patient’s ZIP Code
0–25th percentile (Ref) - - - -
26th to 50th percentile (median) 0.96 0.88 1.06 0.45
51st to 75th percentile 1.02 0.92 1.13 0.69
76th to 100th percentile 1.09 0.98 1.21 0.13
Primary Expected Payer
Medicaid vs. Medicare 1.08 0.76 1.52 0.67
Private insurance vs. Medicare 1.51 1.32 1.74 <0.0001
Self-pay vs. Medicare 1.29 0.81 2.05 0.29
No charge vs. Medicare 0.00 0.00 N/A 1.00
Others vs. Medicare 3.12 2.60 3.76 <0.0001
Admission Day: Admitted Weekday vs. Weekend 1.03 0.96 1.12 0.39
Admission Type: Non-elective vs. Elective admission 1.11 0.90 1.36 0.33
All Patient Refined DRG: Severity of Illness Subclass
Minor loss of function (Ref) - - - -
Moderate loss of function 2.02 1.49 2.73 <0.0001
Major loss of function 9.57 7.14 12.84 <0.0001
Extreme loss of function 48.57 36.15 65.26 <0.0001
Comorbidities
AIDS 0.00 0.00 N/A 1.00
Alcohol abuse 1.24 0.99 1.55 0.06
Deficiency anemias 0.87 0.80 0.95 0.00
Rheumatoid arthritis/collagen vascular diseases 1.07 0.89 1.29 0.45
Chronic blood loss anemia 0.73 0.49 1.10 0.14
Congestive heart failure 1.20 1.10 1.31 <0.0001
Chronic pulmonary disease 0.93 0.86 1.01 0.08
Coagulopathy 1.18 1.05 1.32 0.01
Depression 0.83 0.73 0.94 0.00
Drug abuse 0.57 0.33 0.96 0.04
Hypertension (combine uncomplicated and complicated) 0.88 0.81 0.95 0.00
Hypothyroidism 0.89 0.81 0.98 0.02
Liver disease 1.21 0.94 1.56 0.14
Lymphoma 0.77 0.58 1.02 0.07
Fluid and electrolyte disorders 1.11 1.03 1.19 0.00
Other neurological disorders 1.16 1.04 1.30 0.01
Obesity 0.77 0.66 0.91 0.00
Paralysis 1.21 1.04 1.41 0.01
Peripheral vascular disorders 0.97 0.87 1.09 0.65
Psychoses 1.26 1.01 1.58 0.04
Pulmonary circulation disorders 0.94 0.82 1.08 0.41
Renal failure 0.96 0.88 1.05 0.34
Solid tumor without metastasis 1.58 1.35 1.85 <0.0001
Metastatic cancer 2.30 2.00 2.64 <0.0001
Valvular disease 0.77 0.69 0.86 <0.0001
Weight loss 0.74 0.68 0.80 <0.0001
Number of Chronic Conditions
1–4 (Ref) - - - -
5–6 0.90 0.81 1.00 0.06
7–8 0.84 0.75 0.95 0.00
>8 0.80 0.70 0.92 0.00
Hospital Characteristics
Bed size of hospital: Medium vs. Small 1.06 0.94 1.18 0.35
Large vs. Small 1.00 0.90 1.11 0.99
Hospital urban–rural designation
Large metropolitan areas with at least 1 million residents (Ref) - - - -
Small metropolitan areas with less than 1 million residents 1.32 1.10 1.58 0.0025
Micropolitan areas 0.67 0.51 0.88 0.0044
Not metropolitan or micropolitan (non-urban residual) 1.00 1.00 1.00 N/A
Teaching status of urban hospitals:
Metropolitan teaching vs. metropolitan non-teaching 0.91 0.84 0.99 0.02
Control/ownership of hospital:
Private, not-profit vs. government, nonfederal 1.01 0.92 1.12 0.80
Private, invest-own vs. government, nonfederal 1.14 1.00 1.30 0.04